jama ophthalmology semaglutide 📌 Most viewed this week from Ophthalmology: #Semaglutide, taken for diabetes or obesity, was associated with non-arteritic anterior ischemic optic neuropathy (NAION). https://t.co/ca4OGpC9MS Semaglutide or Tirzepatide and Optic

Key takeaways Ozempic and Jardiance are FDA approved to treat Type 2 diabetes but differ in mechanism of action, active ingredients, dosage forms, and side effects

Treatment with an AOM often follows a pattern of initial weight loss that tends to level out, or plateau, after a period of time on treatment [54, 56, 57]

Furthermore, GLP-1 levels increase following bariatric surgery and it is thought that these increased GLP-1 levels play some role in the changes in appetite that occur following bariatric surgery

NEJM 392:958971 Korsatko et al

Hence, senolytic therapies may be a suitable approach for increasing therapy sensitivity and preventing cancer relapse 10